A Model to Predict Treatment Failure in Patients Undergoing Upfront Surgery for Resectable Colorectal Liver Metastases

Speaking of SurgOnc

English - June 13, 2023 05:00 - 12 minutes - 16.5 MB - ★★★★★ - 6 ratings
Natural Sciences Science education globalcancersurgery research surgicaloncology Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Integration of Universal Germline Genetic Testing for All New Breast Cancer Patients

Next Episode: Exploring the Potential of Artificial Intelligence in Surgery: Insights from a Conversation with ChatGPT

Rick Greene, MD, discusses with Giammauro Berardi, MD, PhD, FEBS, the outcomes of a large cohort of patients undergoing upfront surgery for resectable colorectal liver metastases (CRLM) to analyze the predictability and probability of early treatment failure using clinicopathological characteristics. Dr. Berardi is author of, “A Model to Predict Treatment Failure in Patients Undergoing Upfront Surgery for Resectable Colorectal Liver Metastases.”

Dr. Berardi is attending at the Department of HPB Surgery and Liver Transplantation of the San Camillo Forlanini Hospital, Rome, Italy, and previous to that was a Surgical Oncology clinical fellow at Memorial Sloan-Kettering Cancer Center, New York NY.